AVALGLUCOSIDASE ALFA-NGPT

998 reported adverse events

Drug classes: Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]

These side effects are most commonly reported by patients taking AVALGLUCOSIDASE ALFA-NGPT:

# Side effect Count
0 DRUG SPECIFIC ANTIBODY PRESENT 150
1 OFF LABEL USE 100
2 WEIGHT INCREASED 64
3 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52
4 WEIGHT DECREASED 46
5 PYREXIA 39
6 FATIGUE 36
7 DYSPNOEA 35
8 CONDITION AGGRAVATED 32
9 ILLNESS 32
See all common reactions for AVALGLUCOSIDASE ALFA-NGPT

AVALGLUCOSIDASE ALFA-NGPT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINARY HEXOSE TETRASACCHARIDE INCREASED 16 0.4103
1 COMPLEMENT FACTOR C3 2 0.2857
2 TONSILLAR ATROPHY 1 0.1667
3 GLYCOGEN STORAGE DISEASE TYPE II 11 0.1048
4 ELECTROCARDIOGRAM PACEMAKER SPIKE 1 0.0833
5 COMPLEMENT FACTOR C3 INCREASED 7 0.0667
6 CAPRIPOX VIRAL INFECTION 1 0.0588
7 LYSOSOMAL STORAGE DISORDER 1 0.0526
8 RASH NEONATAL 1 0.0303
9 MACULAR TELANGIECTASIA 1 0.0303
See all enriched reactions for AVALGLUCOSIDASE ALFA-NGPT